HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Deborah F Smith Selected Research

glycylpeptide N-tetradecanoyltransferase

6/2016Global Profiling and Inhibition of Protein Lipidation in Vector and Host Stages of the Sleeping Sickness Parasite Trypanosoma brucei.
10/2014Structure-based design of potent and selective Leishmania N-myristoyltransferase inhibitors.
7/2014Diverse modes of binding in structures of Leishmania major N-myristoyltransferase with selective inhibitors.
1/2012Selective inhibitors of protozoan protein N-myristoyltransferases as starting points for tropical disease medicinal chemistry programs.
4/2010N-myristoyltransferase inhibitors as new leads to treat sleeping sickness.
3/2010N-myristoyltransferase from Leishmania donovani: structural and functional characterisation of a potential drug target for visceral leishmaniasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Deborah F Smith Research Topics

Disease

9Infections
01/2012 - 02/2003
4Visceral Leishmaniasis (Kala Azar)
05/2017 - 10/2003
4Leishmaniasis
05/2017 - 09/2010
3African Trypanosomiasis (Nagana)
06/2016 - 04/2010
2Parasitic Diseases (Parasitic Disease)
07/2014 - 02/2003
2Bardet-Biedl Syndrome (Syndrome, Bardet-Biedl)
02/2013 - 07/2012
1Ciliopathies
02/2013
1Inborn Genetic Diseases (Disease, Hereditary)
07/2012
1Cicatrix (Scar)
01/2012
1Cutaneous Leishmaniasis
03/2011
1Trypanosomiasis
04/2010
1Granuloma
03/2010
1Polycystic Kidney Diseases (Polycystic Kidney Disease)
05/2005
1Communicable Diseases (Infectious Diseases)
10/2003
1Acquired Immunodeficiency Syndrome (AIDS)
02/2003
1Malaria
02/2003
1Mycoses (Diseases, Fungus)
02/2003

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
06/2016 - 02/2003
6glycylpeptide N-tetradecanoyltransferaseIBA
06/2016 - 03/2010
4VaccinesIBA
05/2017 - 10/2003
4Pharmaceutical PreparationsIBA
06/2016 - 02/2003
3EnzymesIBA
06/2016 - 02/2003
3Monomeric GTP-Binding ProteinsIBA
02/2013 - 01/2012
3AntigensIBA
03/2010 - 01/2006
2Toll-Like Receptors (Toll-Like Receptor)IBA
09/2004 - 04/2004
2Complement System Proteins (Complement)IBA
11/2003 - 10/2003
1Myristic Acid (Tetradecanoic Acid)IBA
06/2016
1Serine C-PalmitoyltransferaseIBA
01/2012
1SNARE Proteins (SNAREs)IBA
01/2012
1Immune Sera (Antisera)IBA
09/2010
1Peptides (Polypeptides)IBA
03/2010
1RNA (Ribonucleic Acid)IBA
07/2009
1Interleukin-10 (Interleukin 10)IBA
07/2006
1ChemokinesIBA
09/2004
1Chemokine CCL5IBA
09/2004
1Toll-Like Receptor 4IBA
04/2004
1AntibodiesIBA
10/2003
1TransferasesIBA
02/2003

Therapy/Procedure

2Therapeutics
03/2012 - 02/2003
1Drug Therapy (Chemotherapy)
05/2017